Page last updated: 2024-09-04

cycloastragenol and Cerebral Infarction, Middle Cerebral Artery

cycloastragenol has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dou, BK; Han, HZ; Ke, ZJ; Li, M; Li, SC; Liu, DX; Wang, ZF; Zou, YX	1

Other Studies

1 other study(ies) available for cycloastragenol and Cerebral Infarction, Middle Cerebral Artery

Article	Year
Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia. Acta pharmacologica Sinica, 2020, Volume: 41, Issue:8 Topics: Animals; Apoptosis; Blood-Brain Barrier; Infarction, Middle Cerebral Artery; Inflammation; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B p50 Subunit; Sapogenins; Signal Transduction; Sirtuin 1; Tight Junctions; Tumor Suppressor Protein p53; Up-Regulation	2020

Article

Year

Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia.

Acta pharmacologica Sinica, 2020, Volume: 41, Issue:8

Topics: Animals; Apoptosis; Blood-Brain Barrier; Infarction, Middle Cerebral Artery; Inflammation; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B p50 Subunit; Sapogenins; Signal Transduction; Sirtuin 1; Tight Junctions; Tumor Suppressor Protein p53; Up-Regulation

2020